To read our full disclaimer, click here.
This is a business with:
Revenue up 34% in the quarter it just reported
Operating income more than doubled
78% gross margins
$85 million of contracted revenue still to be recognised
$63 million of cash and no bank debt
A leading position in a corner of mental health that is going mainstream
The same release steered full-year results to the top of guidance.
Since then the stock has fallen 25%.
It closed at $8.73 on 19 November, half its 52-week high.
Category leader. Recurring revenue. Operating leverage. Sentiment reset.
Here’s everything you need to know...

